SCHEDULE 14C INFORMATION
Information Statement Pursuant to Section 14 (c) of the
Securities Exchange Act of 1934
Filed by the Registrant ☒ | Filed by a Party other than the Registrant ☐ |
Check the appropriate box: | ||
☐ | Preliminary Information Statement | |
☐ | Confidential, for Use of Commission Only [as permitted by Rule 14a-6(e) (2)] | |
☒ | Definitive Information Statement |
TRANSAMERICA FUNDS
(Name of Registrant as Specified in Its Charter)
Payment of Filing Fee (Check the appropriate box): | ||||
☒ | No fee required | |||
☐ | $125 per Exchange Act Rules 0-11(c) (1) (ii), 14 c-(1) (ii), 14c-5(g). | |||
☐ | Fee computed on table below per Exchange Act Rules 14c-5(g) and 0-11. | |||
1) | Title of each class of securities to which transaction applies:
| |||
| ||||
2) | Aggregate number of securities to which transaction applies:
| |||
| ||||
3) | Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (Set forth the amount on which the filing fee is calculated and state how it was determined):
| |||
| ||||
4) | Proposed maximum aggregate value of transaction:
| |||
| ||||
5) | Total fee paid: | |||
| ||||
☐ | Fee paid previously with preliminary materials. | |||
☐ | Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a) (2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing. | |||
1) | Amount Previously Paid:
| |||
| ||||
2) | Form, Schedule or Registration Statement No.:
| |||
| ||||
3) | Filing Party:
| |||
| ||||
Date Filed:
| ||||
|
TRANSAMERICA FUNDS
Transamerica Emerging Markets Equity
Transamerica International Stock
1801 California Street, Suite 5200
Denver, CO 80202
June 28, 2019
Thank you for being a valued Transamerica shareholder.
We are reaching out to provide you with additional information regarding the approval by the Board of Trustees (the “Board”) of Transamerica Funds (the “Trust”) of a newsub-advisory agreement (the “NewSub-Advisory Agreement”) with respect to Transamerica Emerging Markets Equity and Transamerica International Stock (each a “Fund” and collectively, the “Funds”). Each Fund is a series of the Trust. No action is required on your part. We do, however, ask that you review the enclosed Information Statement, which contains information about the NewSub-Advisory Agreement for your Fund(s). We encourage you to store this document with your Transamerica investment information.
ClariVest Asset Management LLC (“ClariVest”) remains thesub-adviser to each Fund. ClariVest previouslysub-advised the Funds pursuant to an investmentsub-advisory agreement dated December 24, 2012, as amended (the “PriorSub-Advisory Agreement”), between ClariVest and Transamerica Asset Management, Inc. (“TAM”), the Funds’ investment manager. The NewSub-Advisory Agreement became effective on March 31, 2019, upon the closing of a transaction in which Eagle Asset Management, Inc. (“Eagle”) increased its ownership interest in ClariVest. ClariVest is now a wholly-owned subsidiary of Eagle. This transaction constituted an “assignment,” as that term is defined in the Investment Company Act of 1940, as amended, of the PriorSub-Advisory Agreement with ClariVest and resulted in the automatic termination of the agreement. In anticipation of the transaction, the Board considered and unanimously approved the continued retention of ClariVest as the Funds’sub-adviser and approved the NewSub-Advisory Agreement with ClariVest to take effect upon the closing of the transaction. In approving the NewSub-Advisory Agreement, the Board considered, among other things, that the transaction is not expected to result in any diminution in the nature, extent and quality ofsub-advisory services provided by ClariVest to the Funds. TAM continues to serve as each Fund’s investment manager. The enclosed Information Statement contains information regarding the NewSub-Advisory Agreement.
If you have any questions, please call the following number between 8 a.m. and 5 p.m., Eastern Time, Monday through Friday:1-888-233-4339.
Thank you, again, for your continued business.
Sincerely, |
/s/ Marijn P. Smit |
Marijn P. Smit |
Chairman, President and |
Chief Executive Officer |
Information Statement
TRANSAMERICA FUNDS
Transamerica Emerging Markets Equity
Transamerica International Stock
June 28, 2019
Summary
This information statement (“Information Statement”) is being furnished by the Board of Trustees (the “Board” or “Board Members”) of Transamerica Funds (the “Trust”) to the respective shareholders of Transamerica Emerging Markets Equity and Transamerica International Stock (each a “Fund” and collectively, the “Funds”). Transamerica Funds, a registered investment company, is organized as a Delaware statutory trust.
This Information Statement provides information regarding the approval by the Board of a newsub-advisory agreement with respect to the Funds. The Funds continue to besub-advised by ClariVest Asset Management LLC (“ClariVest”), pursuant to a newsub-advisory agreement between Transamerica Asset Management, Inc. (“TAM”) and ClariVest, a copy of which is attached hereto asExhibit A (the “NewSub-Advisory Agreement”). The NewSub-Advisory Agreement became necessary due to the closing of a transaction that resulted in an assignment and automatic termination of the priorsub-advisory agreement between TAM and ClariVest (the “PriorSub-Advisory Agreement”).
The NewSub-Advisory Agreement became effective on March 31, 2019, upon the closing of a transaction in which Eagle Asset Management, Inc. (“Eagle”) increased its ownership interest in ClariVest by acquiring the remaining 55% equity interest in ClariVest. ClariVest is now a wholly-owned subsidiary of Eagle. This transaction constituted an “assignment,” as that term is defined in the Investment Company Act of 1940, as amended (the “1940 Act”), of the PriorSub-Advisory Agreement with ClariVest and resulted in the automatic termination of the agreement. In anticipation of the transaction, the Board approved the continued retention of ClariVest as the Funds’sub-adviser and approved the NewSub-Advisory Agreement with ClariVest to take effect upon the closing of the transaction.
This Information Statement is provided in lieu of a proxy statement to each Fund’s shareholders as of March 31, 2019 (the “Record Date”), pursuant to the terms of an exemptive order (the “Order”) issued by the U.S. Securities and Exchange Commission (the “SEC”) on August 5, 1998. The Order permits TAM to enter into and materially amendsub-advisory agreements (withnon-affiliated entities) subject to the approval of the Board, including a majority of Board Members who are not parties to the agreements and are not interested persons, as defined in the 1940 Act, of the parties to the agreement (the “Independent Board Members”), without obtaining shareholder approval. Pursuant to the Order, however, each Fund is required to provide certain information about a newsub-advisory agreement to its shareholders.
A Notice of Internet Availability of the Information Statement is being mailed on or about June 28, 2019. ClariVest will bear the costs associated with preparing and distributing this Information Statement and the Notice of Internet Availability of the Information Statement to the Funds’ respective shareholders.
The annual reports of the Funds are sent to shareholders of record following the Funds’ fiscal year end. The fiscal year end of the Funds is October 31. The Funds will furnish, without charge, a copy of their most recent annual andsemi-annual reports to a shareholder upon request. Such requests should be directed to the Funds by calling toll free1-888-233-4339, or writing to the Funds at 1801 California Street, Suite 5200, Denver, CO 80202. Copies of the most recent annual and semi-annual reports of each Fund are also available on the EDGAR Database on the SEC’s Internet site atwww.sec.gov.
The enclosed material is for your information only. It is not a proxy statement and you are not being asked to vote. Please note that only one copy of the Notice of Internet Availability or this Information Statement, as applicable, may be delivered to two or more shareholders who share an address, unless the Funds have received instructions to the contrary. Please contact the Funds at the address and phone number set forth above if you have any questions.
We Are Not Asking You For a Proxy and You Are Requested Not To Send Us a Proxy.
This Information Statement will be available on the Transamerica website until at least December 31, 2019 athttps://www.transamerica.com/media/tf-clarivest-to-eagle-info-statement.pdf. A paper or email copy of this Information Statement may be obtained, without charge, by contacting the Funds at1-888-233-4339.
1
TRANSAMERICA FUNDS
Transamerica Emerging Markets Equity
Transamerica International Stock
QUESTIONS AND ANSWERS
Q. | Why am I receiving this Information Statement? |
A. | This Information Statement is being furnished by the Board to provide information to shareholders of the Funds regarding the NewSub-Advisory Agreement for the Funds. The Board, upon the recommendation of TAM, has approved the NewSub-Advisory Agreement between TAM and ClariVest with respect to the Funds. |
The Funds have obtained exemptive relief from the SEC that permits TAM to enter into newsub-advisory agreements, subject to Board approval and without shareholder approval under certain circumstances. Pursuant to the exemptive order, the Funds have agreed to provide shareholders with certain information regarding such newsub-advisory agreements.
Q. | Am I being asked to vote on anything? |
A. | No. This Information Statement is being provided to each Fund’s shareholders in lieu of a proxy statement pursuant to the terms of the exemptive order. You are not being asked to vote on the NewSub-Advisory Agreement, but you are encouraged to review this Information Statement. |
Q. | What is TAM’s role as a manager of managers? |
A. | TAM acts as a “manager of managers” for the Funds. TAM recommended to the Board the continued retention of ClariVest as each Fund’ssub-adviser and the approval of the NewSub-Advisory Agreement with respect to the Funds. In acting as a manager of managers, TAM provides investment management services that include, without limitation, selection, proactive oversight and monitoring of thesub-adviser, daily monitoring of thesub-adviser’s buying and selling of securities for each Fund, and regular review and evaluation of thesub-adviser’s performance and adherence to investment style and process. |
Q. | Why did TAM recommend and the Board approve the NewSub-Advisory Agreement with ClariVest? |
A. | The material terms of the NewSub-Advisory Agreement are substantially similar to the material terms of the PriorSub-Advisory Agreement between ClariVest and TAM. The services provided by ClariVest to the Funds and thesub-advisory fee rates payable to ClariVest with respect to each Fund under the NewSub-Advisory Agreement have remain unchanged. TAM understands that ClariVest will retain the same investment processes, trade operations functions, and many of the same investment personnel as under the PriorSub-Advisory Agreement. TAM and ClariVest expect there to be no diminution in the nature, extent and quality of the services that ClariVest provides to each Fund as a result of the transaction. After discussion, the Board approved the continued retention of ClariVest as each Fund’ssub-adviser and the NewSub-Advisory Agreement. The key factors considered by the Board are discussed later in the “Evaluation by the Board” section of this Information Statement. |
2
INFORMATION STATEMENT
This Information Statement describes ClariVest and the terms of the NewSub-Advisory Agreement.
At a meeting of the Board held on March6-7, 2019, the Board approved, at TAM’s recommendation, the NewSub-Advisory Agreement effective upon the closing of the transaction.
The PriorSub-Advisory Agreement terminated automatically on March 31, 2019 upon the closing of the transaction discussed above. The transaction constituted an “assignment” of the PriorSub-Advisory Agreement under the 1940 Act, resulting in the automatic termination of the PriorSub-Advisory Agreement. This gave rise to the necessity for the Board to approve, at anin-person meeting, the NewSub-Advisory Agreement between TAM and ClariVest with respect to the Funds.
THE FUNDS AND THEIR MANAGEMENT AGREEMENT
TAM, a Florida corporation located at 1801 California Street, Suite 5200, Denver, CO 80202, manages the assets of each Fund pursuant to a Management Agreement (the “Management Agreement”), dated March 1, 2016, which was last approved by the Board, including a majority of the Independent Board Members, on June19-20, 2019. TAM is directly owned by Transamerica Premier Life Insurance Company (“TPLIC”) (77%) and AUSA Holding, LLC (“AUSA”) (23%), both of which are indirect, wholly owned subsidiaries of Aegon NV. TPLIC is owned by Commonwealth General Corporation (“Commonwealth”). Commonwealth and AUSA are wholly owned by Transamerica Corporation (DE). Transamerica Corporation (DE) is wholly owned by The Aegon Trust, which is wholly owned by Aegon International B.V., which is wholly owned by Aegon NV, a Netherlands corporation and a publicly traded international insurance group.
Subject to the terms of the Management Agreement, TAM, among other things: (i) regularly provides each Fund with investment management services, including management, supervision and investment research and advice, (ii) furnishes a continuous investment program for each Fund’s portfolio of securities and other investments consistent with each Fund’s investment objectives, policies and restrictions, as stated in each Fund’s current registration statement, (iii) provides supervisory, compliance and administrative services to each Fund, and (iv) provides any additional services incidental to the foregoing services. TAM is permitted to enter into contracts withsub-advisers, subject to the Board’s approval. The services that TAM provides to the Funds under the Management Agreement are not expected to change in light of the transaction.
No officer or Board Member of the Funds is a director, officer or employee of ClariVest. No officer or Board Member of the Funds, through the ownership of securities or otherwise, has any other material direct or indirect interest in ClariVest or any other person controlling, controlled by or under common control with ClariVest. Since the Record Date, none of the Board Members of the Funds have had any material interest, direct or indirect, in any material transactions, or in any material proposed transactions, to which ClariVest or any of its affiliates was or is to be a party.
TERMS OF THE PRIORSUB-ADVISORY AGREEMENT
ClariVest has served assub-adviser to Transamerica Emerging Markets Equity and Transamerica International Stock since December 24, 2012 and September 28, 2018, respectively. ClariVest providedsub-advisory services to each Fund pursuant to the PriorSub-Advisory Agreement. The PriorSub-Advisory Agreement was last approved by the Board, including a majority of the Independent Board Members, on June21-22, 2018 with respect to Transamerica Emerging Markets Equity and September12-13, 2018 with respect to Transamerica International Stock.
COMPARISON OF THESUB-ADVISORY AGREEMENT
Descriptions of thesub-advisory fee rates payable by TAM to ClariVest appear below under the caption“Sub-Advisory Fees.”
As discussed below under the caption “Evaluation by the Board,” the Board authorized TAM to enter into the NewSub-Advisory Agreement, effective upon the closing of the transaction. The NewSub-Advisory Agreement was approved by the Board on March6-7, 2019 and became effective as of March 31, 2019. The NewSub-Advisory Agreement has an initial term of two years from its effective date (unless sooner terminated in accordance with its terms). Thereafter, continuance of the NewSub-Advisory Agreement is subject to the specific approval, at least annually, by vote of a majority of the Independent Board Members, at a meeting called for the purpose of voting on such approval, and by either the Board or an affirmative vote of the majority of outstanding voting securities (as that term is defined in the 1940 Act) of the applicable Fund.
The terms of the PriorSub-Advisory Agreement and those of the NewSub-Advisory Agreement are substantially similar. The management fee schedule payable by the Funds to TAM, and thesub-advisory fee rates payable by TAM to ClariVest are unchanged under the NewSub-Advisory Agreement.
3
Under the terms of the New Sub-Advisory Agreement, subject to the supervision of the Trust’s Board and TAM, ClariVest shall regularly provide the Funds (with respect to such portion of each Fund’s assets as shall be allocated to ClariVest by TAM from time to time (the “Allocated Assets”)) with investment research, advice, management and supervision and shall furnish a continuous investment program for the Allocated Assets consistent with each Fund’s investment objectives, policies and restrictions, as stated in each Fund’s current Prospectuses and Statement of Additional Information, and subject to such other restrictions and limitations as directed by the officers of TAM or the Trust by reasonable notice in writing to ClariVest. The PriorSub-Advisory Agreement contained the same provisions.
The NewSub-Advisory Agreement provides that ClariVest will place orders for the purchase and sale of portfolio securities with the issuer or with such broker-dealers who provide research and brokerage services to the Funds within the meaning of Section 28(e) of the Securities Exchange Act of 1934, to ClariVest, or to any other fund or account over which ClariVest or its affiliates exercise investment discretion. The NewSub-Advisory Agreement also provides that, subject to such policies and procedures as may be adopted by the Board and officers of the Funds, ClariVest may pay a broker or dealer an amount of commission for effecting a securities transaction in excess of the amount of commission another broker or dealer would have charged for effecting that transaction, in such instances where ClariVest has determined in good faith that such amount of commission was reasonable in relation to the value of the brokerage and research services provided by such broker or dealer, viewed in terms of either that particular transaction or ClariVest’s overall responsibilities with respect to the Funds and to other funds and clients for which ClariVest exercises investment discretion. The Board may adopt policies and procedures that modify and restrict ClariVest’s authority regarding the execution of each Fund’s portfolio transactions. The PriorSub-Advisory Agreement contained the same provisions.
The NewSub-Advisory Agreement provides that it: (i) may be terminated with respect to the applicable Fund at any time, without penalty, either by vote of the Board or by vote of a majority of the outstanding voting securities of the applicable Fund; (ii) may be terminated by TAM upon written notice to ClariVest, without the payment of any penalty; (iii) may be terminated by ClariVest upon 90 days’ advance written notice to TAM; and (iv) will terminate automatically in the event of its assignment (within the meaning of the 1940 Act) by ClariVest and shall not be assignable by TAM without the consent of ClariVest. The PriorSub-Advisory Agreement contained similar provisions, with the exception that the PriorSub-Advisory Agreement was terminable by ClariVest upon 60 days’ advance written notice to TAM.
The New Sub-Advisory Agreement requires that ClariVest, at its expense, supply the Board, the officers of the Trust and TAM with all information and reports reasonably required by them and reasonably available to ClariVest relating to the services provided pursuant to the NewSub-Advisory Agreement, including such information that the Funds’ Chief Compliance Officer reasonably believes necessary for compliance with Rule38a-1 under the 1940 Act. The PriorSub-Advisory Agreement contained the same provisions.
The NewSub-Advisory Agreement states that ClariVest shall be responsible only for rendering the services called for thereunder in good faith and shall not be liable for any error of judgment or mistake of law, or for any loss arising out of any investment or for any act or omission in the execution of services thereunder, provided that ClariVest is not protected against any liability to TAM or the Funds to which ClariVest would otherwise be subject by reason of willful misfeasance, bad faith, or gross negligence in the performance of its duties or by reason of its reckless disregard of its obligations and duties under the NewSub-Advisory Agreement. The PriorSub-Advisory Agreement contained the same provisions.
The NewSub-Advisory Agreement provides that unless TAM advises ClariVest in writing that the right to vote proxies has been expressly reserved to TAM or the Trust or otherwise delegated to another party, ClariVest shall exercise voting rights incident to any security purchased with, or comprising a portion of, each Fund’s securities managed by ClariVest, in accordance with ClariVest’s proxy voting policies and procedures without consultation with TAM or the Funds. The PriorSub-Advisory Agreement contained the same provisions.
The NewSub-Advisory Agreement provides that ClariVest, in performance of its duties, is and shall be an independent contractor and, unless otherwise expressly provided in the NewSub-Advisory Agreement or otherwise authorized in writing, shall have no authority to act for or represent the Funds of TAM in any way or otherwise be deemed to be an agent of the Funds or TAM. The PriorSub-Advisory Agreement did not contain a similar provision.
The NewSub-Advisory Agreement requires ClariVest to make certain representations and covenants, including concerning ClariVest’s review of each Fund’s registration statement, the registration statement disclosure being consistent with the manner in which ClariVest is managing each Fund, and ClariVest’s commitment to promptly notify TAM and the Trust in the event the registration statement disclosure becomes inaccurate or incomplete. The PriorSub-Advisory Agreement contained the same provisions.
4
The NewSub-Advisory Agreement provides that it shall be construed and the provisions thereof interpreted under and in accordance with the laws of the State of New York without regard to conflicts of laws principles. The PriorSub-Advisory Agreement provided that it shall be construed and the provisions thereof interpreted under and in accordance with the laws of the State of Florida.
Shareholders should refer toExhibit A attached hereto for the complete terms of the NewSub-Advisory Agreement. The summary of the NewSub-Advisory Agreement set forth herein is qualified in its entirety by provisions of the New Sub-Advisory Agreement as set forth inExhibit A.
TAM MANAGEMENT FEES
In connection with the transaction, the management fee schedule payable by the Funds to TAM did not change. Under the Management Agreement, each Fund currently pays TAM on an annual basis the following management fee based on its average daily net assets:
Transamerica Emerging Markets Equity
First $250 million | 0.95 | % | ||
Over $250 million up to $500 million | 0.91 | % | ||
Over $500 million up to $1 billion | 0.86 | % | ||
In excess of $1 billion | 0.84 | % |
Transamerica International Stock
First $500 million | 0.70 | % | ||
Over $500 million up to $1 billion | 0.68 | % | ||
Over $1 billion up to $2 billion | 0.67 | % | ||
Over $2 billion up to $3 billion | 0.64 | % | ||
In excess of $3 billion | 0.63 | % |
Management fees are accrued daily and paid by each Fund monthly. As of May 31, 2019, the net assets of the Transamerica Emerging Markets Equity were $807,714,051 and the net assets of Transamerica International Stock were $1,829,044.
SUB-ADVISORY FEES
The NewSub-Advisory Agreement’s fee schedule is identical to that of the PriorSub-Advisory Agreement.
Under the NewSub-Advisory Agreement, TAM (not the Funds) pays ClariVest the followingsub-advisory fees for its services with respect to the Funds’ average daily net assets on an annual basis:
Transamerica Emerging Markets Equity
First $250 million | 0.49 | % | ||
Over $250 million up to $500 million | 0.45 | % | ||
Over $500 million up to $1 billion | 0.43 | % | ||
Over $1 billion | 0.41 | % |
Transamerica International Stock
First $500 million | 0.25 | % | ||
Over $500 million up to $1 billion | 0.23 | % | ||
Over $1 billion up to $2 billion | 0.22 | % | ||
Over $2 billion up to $3 billion | 0.21 | % | ||
Over $3 billion | 0.20 | % |
Effective September 28, 2018, ClariVest agreed to reduce itssub-advisory fee by 5% if combined assets of the Funds are over $500 million up to $1.5 billion; by 7.5% if combined assets of the Funds are over $1.5 billion up to $3 billion; and by 10% if combined assets of the Funds are in excess of $3 billion. TAM has agreed to voluntarily waive its management fees on the Funds to reflect any savings resulting from ClariVest’s reduction in itssub-advisory fees.
5
The following tables show the management fees paid to TAM (with and without regard to waivers/expense reimbursements and recapture) andsub-advisory fees paid by TAM to ClariVest under the PriorSub-Advisory Agreement for the fiscal year ended October 31, 2018.
Transamerica Emerging Markets Equity
Management Fees Payable to TAM (prior to waiver/expense | Management Fees Waived/Expenses Reimbursed | Management Fees Paid to TAM (after waivers/expense reimbursements and recapture) | Sub-Advisory Fees Paid by TAM to ClariVest | |||
$5,036,202 | $8,328 | $5,027,874 | $2,582,019 |
Transamerica International Stock
Management Fees Payable to TAM (prior to waiver/expense | Management Fees Waived/Expenses Reimbursed | Management Fees Paid to TAM (after waivers/expense reimbursements and recapture) | Sub-Advisory Fees Paid by TAM to ClariVest | |||
$1,280 | $24,463 | ($23,183) | $439 |
INFORMATION REGARDING THESUB-ADVISER
ClariVest is a registered investment adviser with the SEC providing asset management services since 2006. As of December 31, 2018, ClariVest managed approximately $6.4 billion in total assets. ClariVest, located at 3611 Valley Centre Drive, Suite 100, San Diego, CA 92130, is a direct, wholly-owned subsidiary of Eagle.
Eagle, located at 880 Carillon Parkway, St. Petersburg, FL 33716, is a registered investment adviser with the SEC. Eagle is a direct, wholly-owned subsidiary of Carillon Tower Advisers, Inc. (“Carillon Tower”).
Carillon Tower, located at 880 Carillon Parkway, St. Petersburg, FL 33716, is a registered investment adviser with the SEC. Carillon Tower is a direct, wholly-owned subsidiary of Raymond James Financial, Inc.
Portfolio Managers
Transamerica Emerging Markets Equity
Name | Sub-Adviser | Positions Over Past Five Years | ||
Priyanshu Mutreja, CFA | ClariVest | Portfolio Manager of the Fund since 2017; Assistant Portfolio Manager of the Fund since 2014; joined ClariVest Asset Management LLC in 2009 | ||
Alex Turner, CFA | ClariVest | Portfolio Manager of the Fund since 2014; Assistant Portfolio Manager of the Fund since 2012; joined ClariVest Asset Management LLC in 2008; Prior to 2008, Quantitative Analytic Specialist at Factset Research Systems, Inc. | ||
David R. Vaughn, CFA | ClariVest | Portfolio Manager of the Fund since 2012; founder of ClariVest Asset Management LLC in 2006; primarily responsible for international, global and emerging market strategies |
Transamerica International Stock
Name | Sub-Adviser | Positions Over Past Five Years | ||
Priyanshu Mutreja, CFA | ClariVest | Portfolio Manager of the Fund since 2018; joined ClariVest Asset Management LLC in 2009 | ||
Alex Turner, CFA | ClariVest | Portfolio Manager of the Fund since 2018; joined ClariVest Asset Management LLC in 2008 | ||
David R. Vaughn, CFA | ClariVest | Portfolio Manager of the Fund since 2018; founder of ClariVest Asset Management LLC in 2006; primarily responsible for international, global and emerging market strategies |
6
Management and Governance
Listed below are the names, positions and principal occupations of the directors and principal executive officers of ClariVest as of May 31, 2019. The principal address of each individual as it relates to his or her duties at ClariVest is the same as that of ClariVest.
Name | Position with ClariVest | |
David Raymond Vaughn | Chief Investment Officer -Non-U.S. and Global Strategies, Member | |
Todd Nathan Wolter | Chief Investment Officer - U.S. and Alternative Strategies, Member | |
Tiffany Ann Ayres | President, General Counsel and Chief Compliance Officer | |
Jeff A. Jacobson | Chief Financial Officer & Chief Operations Officer | |
Eric Wilwant | Member | |
J. Cooper Abbott | Member | |
Aaron Ochstein | Member | |
Court James | Member |
Management Activities. ClariVest acts as advisers orsub-advisers, as indicated, for the following registered investment companies, or series of a registered investment company with investment objectives similar to the Funds:
Comparable Fund for which ClariVest serves as Adviser or Sub-Adviser | Assets Managed by ClariVest (as of May 31, 2019) | Advisory or Sub-Advisory Fee Paid to ClariVest (annually) | ||||||
Carillon ClariVest International Stock Fund | $ | 12.1 million | 0.70 | % |
EVALUATION BY THE BOARD
At a meeting of the Board held on March6-7, 2019, the Board considered the continued retention of ClariVest assub-adviser for the Funds. Following their review and consideration, the Board Members determined that the terms of the NewSub-Advisory Agreement were reasonable, and approval of the NewSub-Advisory Agreement was in the best interests of each Fund and their respective shareholders. The Board, including the Independent Board Members, unanimously approved the NewSub-Advisory Agreement for an initialtwo-year period.
To assist the Board Members in their consideration of the NewSub-Advisory Agreement, the Board Members had requested and received from TAM and ClariVest certain materials and information in advance of the meeting. The Board Members then reviewed such information as they deemed reasonably necessary to evaluate the NewSub-Advisory Agreement. In addition, the Independent Board Members consulted with counsel, including independent legal counsel, discussing, among other things, the legal standards and certain other considerations relevant to the Independent Board Members’ deliberations.
Among other matters, the Board Members considered:
(a) | that Eagle’s purchase is not expected to result in any diminution in the nature, extent and quality ofsub-advisory services provided to the Funds and their shareholders, including compliance services; |
(b) | that, although certain internal service functions (e.g., corporate, accounting and payroll services) will change, ClariVest expects to retain the same investment processes, trade operations functions, and many of the same investment personnel following the transaction; |
(c) | that ClariVest is an experienced and respected asset management firm and TAM believes that ClariVest will continue to have the capabilities, resources and personnel necessary to providesub-advisory services to the Funds based on an assessment of ClariVest, its investment personnel, and thesub-advisory services ClariVest provides to the Funds; and |
7
(d) | that the NewSub-Advisory Agreement will not result in any change in the rate ofsub-advisory fees payable by TAM to ClariVest. |
In approving the NewSub-Advisory Agreement, the Board Members also relied, as to ClariVest’s services, fees, profitability and fallout benefits, on their prior deliberations in approving the continuance of thesub-advisory agreement in June of 2018 and the amendedsub-advisory agreement in September of 2018, as supplemented by the new information concerning the transaction. With respect to other matters, such as TAM’s profitability in operating the Funds with ClariVest as theirsub-adviser, they relied in part upon their prior deliberations in approving the continuance of the management agreement with TAM in June of 2018.
In their deliberations, the Board Members evaluated and weighed a number of considerations that they believed to be relevant in light of the legal advice furnished to them by counsel, including independent legal counsel, and made a decision in the exercise of their own business judgment. The Board Members based their decisions on the considerations discussed above, among others, although they did not identify any particular consideration or item of information that was controlling of their decisions, and each Board Member may have attributed different weights to the various factors.
After consideration of the factors described above, as well as other factors, the Board Members, including all of the Independent Board Members, concluded that the approval of the NewSub-Advisory Agreement is in the best interests of the Funds and their respective shareholders and unanimously approved the NewSub-Advisory Agreement to take effect upon the closing of the transaction.
BROKERAGE INFORMATION
With respect to Transamerica Emerging Markets Equity, there were no brokerage commissions incurred on security transactions placed with affiliates of TAM or ClariVest for the fiscal year ended October 31, 2018.
With respect to Transamerica International Stock, there were no brokerage commissions incurred on security transactions placed with affiliates of TAM or ClariVest for the fiscal year ended October 31, 2018.
ADDITIONAL INFORMATION
TAM, the Trust’s investment manager, Transamerica Fund Services, Inc., the Trust’s transfer agent, and Transamerica Capital, Inc., the Trust’s principal underwriter, are each located at 1801 California Street, Suite 5200, Denver, CO 80202.
As of May 31, 2019, the Board Members and officers of the Trust, individually and as a group, owned beneficially less than 1% of the outstanding shares of Transamerica Emerging Markets Equity and owned beneficially less than 1% of the outstanding shares of Transamerica International Stock.
As of May 31, 2019, the following persons owned of record 5% or more of the outstanding shares of the class identified of Transamerica Emerging Markets Equity:
Name & Address | Fund Name | Class | Percent | |||||
National Financial Services LLC For the Exclusive Benefit of Our Customers 499 Washington Blvd Attn Mutual Fund Dept - 4th Floor Jersey City NJ 07310-1995 | Transamerica Emerging Markets Equity | A | 53.99 | % | ||||
LPL Financial Omnibus Customer Account Attn Mutual Fund Trading 4707 Executive Dr San Diego CA 92121-3091 | Transamerica Emerging Markets Equity | A | 11.76 | % | ||||
Transamerica Asset Management Inc Seed Money Account Attn Corporate Accounting 4333 Edgewood Rd NE Cedar Rapids IA 52499-3830 | Transamerica Emerging Markets Equity | C | 24.70 | % | ||||
National Financial Services LLC For the Exclusive Benefit of Our Customers 499 Washington Blvd Attn Mutual Fund Dept - 4th Floor Jersey City NJ 07310-1995 | Transamerica Emerging Markets Equity | C | 12.23 | % |
8
LPL Financial Omnibus Customer Account Attn Mutual Fund Trading 4707 Executive Dr San Diego CA 92121-3091 | Transamerica Emerging Markets Equity | C | 9.50 | % | ||||
Pershing LLC 1 Pershing Plz Jersey City NJ 07399-0002 | Transamerica Emerging Markets Equity | C | 6.95 | % | ||||
Umb Bank Na Cust Simple IRA FBO Brian S Handa 20315 Calle Montalvo Saratoga CA 95070-6001 | Transamerica Emerging Markets Equity | C | 6.69 | % | ||||
Fifth Third Bank FBO City Of Royal Oak Rhct Mutual 38 Fountain Square Plz Cincinnati OH 45202-3191 | Transamerica Emerging Markets Equity | I | 77.39 | % | ||||
LPL Financial Omnibus Customer Account Attn Mutual Fund Trading 4707 Executive Dr San Diego CA 92121-3091 | Transamerica Emerging Markets Equity | I | 11.66 | % | ||||
Transamerica Asset Allocation - Moderate Growth Portfolio Investment Account Attn Fund Operations Mailstop 20B 1801 California St Ste 5200 Denver CO 80202-2642 | Transamerica Emerging Markets Equity | I2 | 20.65 | % | ||||
Transamerica Asset Allocation-Moderate VP Investment Account Attn Fund Operations Mailstop 20B 1801 California St Ste 5200 Denver CO 80202-2642 | Transamerica Emerging Markets Equity | I2 | 17.97 | % | ||||
Transamerica Asset Allocation-Moderate Growth VP Investment Account Attn Fund Operations Mailstop 20B 1801 California St Ste 5200 Denver CO 80202-2642 | Transamerica Emerging Markets Equity | I2 | 17.46 | % | ||||
Transamerica Asset Allocation - Growth Portfolio Investment Account Attn Fund Operations Mailstop 20B 1801 California St Ste 5200 Denver CO 80202-2642 | Transamerica Emerging Markets Equity | I2 | 17.41 | % | ||||
Transamerica Asset Allocation - Moderate Portfolio Investment Account Attn Fund Operations Mailstop 20B 1801 California St Ste 5200 Denver CO 80202-2642 | Transamerica Emerging Markets Equity | I2 | 10.05 | % |
9
As of May 31, 2019, the following persons owned of record 5% or more of the outstanding shares of the class identified of Transamerica International Stock:
Name & Address | Fund Name | Class | Percent | |||||
Transamerica Asset Management Inc Seed Money Account Attn Corporate Accounting 4333 Edgewood Rd NE Cedar Rapids IA 52499-3830 | Transamerica International Stock | A | 96.52 | % | ||||
Transamerica Asset Management Inc Seed Money Account Attn Corporate Accounting 4333 Edgewood Rd NE Cedar Rapids IA 52499-3830 | Transamerica International Stock | I | 96.13 | % | ||||
Transamerica Asset Management Inc Seed Money Account Attn Corporate Accounting 4333 Edgewood Rd NE Cedar Rapids IA 52499-3830 | Transamerica International Stock | I2 | 100.00 | % | ||||
Transamerica Asset Management Inc Seed Money Account Attn Corporate Accounting 4333 Edgewood Rd NE Cedar Rapids IA 52499-3830 | Transamerica International Stock | R6 | 100.00 | % |
Any shareholder who holds beneficially 25% or more of a Fund may be deemed to control the Fund until such time as such shareholder holds beneficially less than 25% of the outstanding common shares of the Fund. Any shareholder controlling a Fund may be able to determine the outcome of issues that are submitted to shareholders for vote and may be able to take action regarding the Fund without the consent or approval of other shareholders.
As of May 31, 2019, no shareholders owned of record 25% or more of the outstanding shares of Transamerica Emerging Markets Equity.
As of May 31, 2019, no shareholders owned of record 25% or more of the outstanding shares of Transamerica International Stock.
The Trust is a Delaware statutory trust and as such is not required to hold annual meetings of shareholders, although special meetings may be called for the Funds, or for the Trust as a whole, for purposes such as electing or removing Board Members, changing fundamental policies or approving an advisory contract. Shareholder proposals to be presented at any subsequent meeting of shareholders must be received by the Trust at the Trust’s office within a reasonable time before the proxy solicitation is made.
By Order of the Board of Trustees, |
Transamerica Funds |
Rhonda A. Mills |
Secretary |
June 28, 2019
10
EXHIBIT A
INVESTMENT SUBADVISORY AGREEMENT
CLARIVEST ASSET MANAGEMENT LLC.
This Agreement, entered into as of March 31, 2019 by and between Transamerica Asset Management, Inc., a Florida corporation (referred to herein as “TAM”) and ClariVest Asset Management LLC, a Delaware limited liability company (referred to herein as the “Subadviser”).
TAM is the investment adviser to Transamerica Funds (the “Trust”), anopen-end investment company registered under the Investment Company Act of 1940 (collectively with the rules and regulations promulgated thereunder and any exemptive orders thereunder, the “1940 Act”). TAM wishes to engage the Subadviser to provide certain investment advisory services to each series of the Trust listed onSchedule A hereto (the “Fund”). The Subadviser desires to furnish services for the Trust and to perform the functions assigned to it under this Agreement for the considerations provided. Accordingly, the parties have agreed as follows:
1. Appointment. In accordance with the Investment Advisory Agreement between the Trust and TAM (the “Advisory Agreement”), TAM hereby appoints the Subadviser to act as subadviser with respect to the Fund for the period and on the terms set forth in this Agreement. The Subadviser accepts such appointment and agrees to render or cause to be rendered the services set forth for the compensation herein specified.
2. Subadvisory Services. In its capacity as subadviser to the Fund, the Subadviser shall have the following responsibilities:
(a) | Subject to the supervision of the Trust’s Board of Trustees (the “Board”) and TAM, the Subadviser shall regularly provide the Fund with respect to such portion of the Fund’s assets as shall be allocated to the Subadviser by TAM from time to time (the “Allocated Assets”) with investment research, advice, management and supervision and shall furnish a continuous investment program for the Allocated Assets consistent with the Fund’s investment objectives, policies and restrictions, as stated in the Fund’s current Prospectus and Statement of Additional Information, and subject to such other restrictions and limitations as directed by the officers of TAM or the Trust by notice in writing to the Subadviser. The Subadviser shall, with respect to the Allocated Assets, determine from time to time what securities and other investments and instruments will be purchased, retained, sold or exchanged by the Fund and what portion of the Allocated Assets will be held in the various securities and other investments in which the Fund invests, and shall implement those decisions (including the negotiation and execution of investment documentation and agreements, including, without limitation, swap, futures, options and other agreements with counterparties, on the Fund’s behalf as the Subadviser deems appropriate from time to time in order to carry out its responsibilities hereunder, provided the Subadviser provides TAM prompt notice of any new investment agreements and any material amendments to existing investment agreements and the opportunity for legal review), all subject to the provisions of the Trust’s Declaration of Trust andBy-Laws, as may be amended from time to time (collectively, the “Governing Documents”), the 1940 Act and the applicable rules and regulations promulgated thereunder by the Securities and Exchange Commission (the “SEC”), interpretive guidance issued thereunder by the SEC staff and any other applicable federal and state law, as well as the investment objectives, policies and restrictions of the Fund referred to above, any written instructions and directions of the Board or TAM provided to the Subadviser from time to time, and any other specific policies adopted by the Board and disclosed to the Subadviser. The Subadviser’s responsibility for providing investment research, advice, management and supervision to the Fund is limited to that discrete portion of the Fund represented by the Allocated Assets and the Subadviser is prohibited from directly or indirectly consulting with any other subadviser for a portion of the Fund’s assets concerning Fund transactions in securities or other assets. The Subadviser is authorized to give instructions with respect to the Allocated Assets to the custodian of the Fund as to deliveries of securities and other investments and payments of cash for the account of the Fund. Subject to applicable provisions of the 1940 Act, the investment program to be provided hereunder may entail the investment of all or substantially all of the assets of the Fund in one or more investment companies. |
A-1
(b) | The Subadviser will place orders pursuant to its investment determinations for the Fund either directly with the issuer or with any broker or dealer, foreign currency dealer, futures commission merchant or others selected by it. In connection with the selection of such brokers or dealers and the placing of such orders, subject to applicable law, brokers or dealers may be selected who also provide brokerage and research services (as those terms are defined in Section 28(e) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) to the Fund and/or the other accounts over which the Subadviser or its affiliates exercise investment discretion. The Subadviser is authorized to pay a broker or dealer who provides such brokerage and research services a commission for executing a portfolio transaction for the Fund which is in excess of the amount of commission another broker or dealer would have charged for effecting that transaction if the Subadviser determines in good faith that such amount of commission is reasonable in relation to the value of the brokerage and research services provided by such broker or dealer. This determination may be viewed in terms of either that particular transaction or the overall responsibilities which the Subadviser and its affiliates have with respect to accounts over which they exercise investment discretion. The Board may adopt policies and procedures that modify and restrict the Subadviser’s authority regarding the execution of the Fund’s portfolio transactions provided herein. |
(c) | The Fund hereby authorizes any entity or person associated with the Subadviser which is a member of a national securities exchange to effect any transaction on the exchange for the account of the Fund which is permitted by Section 11(a) of the Exchange Act and Rule11a2-2(T) thereunder, and the Fund hereby consents to the retention of compensation for such transactions in accordance with Rule11a2-2(T)(a)(2)(iv). Notwithstanding the foregoing, the Subadviser agrees that it will not deal with itself, or with Trustees of the Trust or any principal underwriter of the Fund, as principals or agents in making purchases or sales of securities or other property for the account of the Fund, nor will it purchase any securities from an underwriting or selling group in which the Subadviser or its affiliates is participating, or arrange for purchases and sales of securities between the Fund and another account advised by the Subadviser or its affiliates, except in each case as permitted by the 1940 Act and in accordance with such policies and procedures as may be adopted by the Fund from time to time, and will comply with all other provisions of the Governing Documents and the Fund’s then-current Prospectus and Statement of Additional Information relative to the Subadviser and its directors and officers. |
(d) | Unless TAM advises the Subadviser in writing that the right to vote proxies has been expressly reserved to TAM or the Trust or otherwise delegated to another party, the Subadviser shall exercise voting rights incident to any security purchased with, or comprising a portion of, the Allocated Assets, in accordance with the Subadviser’s proxy voting policies and procedures without consultation with TAM or the Fund. The Subadviser agrees to furnish a copy of its proxy voting policies and procedures, and any amendments thereto, to TAM. The Subadviser will not act on behalf of TAM or the Fund regarding any legal proceedings, including bankruptcies or class actions, involving the securities held by the Trust and the issuers of those securities. |
(e) | The Subadviser will monitor the security valuations of the Allocated Assets. If the Subadviser believes that the Fund’s carrying value for a security does not fairly represent the price that could be obtained for the security in a current market transaction, the Subadviser will notify TAM promptly. In addition, the Subadviser will be available to consult with TAM in the event of a pricing problem and to participate in the Trust’s Valuation Committee meetings. |
3. Activities of the Subadviser.Nothing in this Agreement shall limit or restrict the right of any director, officer, or employee of the Subadviser to engage in any other business or to devote his or her time and attention in part to the management or other aspects of any other business, whether of a similar nature or a dissimilar nature, nor to limit or restrict the right of the Subadviser to engage in any other business or to render services of any kind, including investment advisory and management services, to any other fund, firm, individual or association. If
A-2
the purchase or sale of securities for the Fund and one or more other accounts of the Subadviser is considered at or about the same time, transactions in such securities will be allocated among the accounts in a manner deemed equitable by the Subadviser. Such transactions may be combined, in accordance with applicable laws and regulations, and consistent with the Subadviser’s policies and procedures as presented to the Board from time to time.
4. Allocation of Charges and Expenses. During the term of this Agreement, the Fund will bear all expenses not expressly assumed by TAM or the Subadviser incurred in the operation of the Fund and the offering of its shares. Without limiting the generality of the foregoing:
(a) | The Fund shall pay its allocable share of (i) fees payable to TAM pursuant to the Advisory Agreement; (ii) the cost (including brokerage commissions, if any) incurred in connection with purchases and sales of the Fund’s portfolio securities; (iii) expenses of organizing the Fund; (iv) filing fees and expenses relating to registering and qualifying and maintaining the registration and qualification of the Fund’s shares for sale under federal and state securities laws; (v) the compensation, fees and reimbursements paid to the Trust’snon-interested Trustees; (vi) custodian and transfer agent fees; (vii) legal and accounting expenses allocable to the Fund, including costs for local representation in the Trust’s jurisdiction of organization and fees and expenses of special counsel, if any, for the independent Trustees; (viii) all federal, state and local tax (including stamp, excise, income and franchise taxes) and the preparation and filing of all returns and reports in connection therewith; (ix) cost of certificates, if any, and delivery to purchasers; (x) expenses of preparing and filing reports with federal and state regulatory authorities; (xi) expenses of shareholders’ meetings and of preparing, printing and distributing proxy statements (unless otherwise agreed to by the Trust and TAM); (xii) costs of any liability, uncollectible items of deposit and other insurance or fidelity bonds; (xiii) any costs, expenses or losses arising out of any liability of, or claim for damage or other relief asserted against, the Trust for violation of any law; (xiv) expenses of preparing, typesetting and printing prospectuses and supplements thereto for existing shareholders and of reports and statements to shareholders; (xv) fees and expenses in connection with membership in investment company organizations and12b-1 fees; and (xvi) any extraordinary expenses incurred by the Trust on behalf of the Fund. |
(b) | TAM shall pay all expenses incurred by it in the performance of its duties under this Agreement. TAM shall also pay all fees payable to the Subadviser pursuant to this Agreement. |
(c) | The Subadviser shall pay all expenses incurred by it in the performance of its duties under this Agreement. The Subadviser shall authorize and permit any of its directors, officers and employees, who may be elected as Trustees or officers of the Trust, to serve in the capacities in which they are elected, and shall pay all compensation, fees and expenses of such Trustees and officers. |
5. Obligation to Provide Information. Each party’s obligation to provide information shall be as follows:
(a) | TAM shall cause the Subadviser to be kept fully informed at all times with regard to the securities owned by the Fund, its funds available, or to become available, for investment, and generally as to the condition of the Fund’s affairs. TAM shall furnish the Subadviser with such other documents and information with regard to the Fund’s affairs as the Subadviser may from time to time reasonably request. |
(b) | The Subadviser, at its expense, shall supply the Board, the officers of the Trust and TAM with all information and reports reasonably required by them and reasonably available to the Subadviser relating to the services provided by the Subadviser hereunder, including such information the Fund’s Chief Compliance Officer reasonably believes necessary for compliance with Rule38a-1 under the 1940 Act. |
A-3
6. Compensation of the Subadviser. As compensation for the services performed by the Subadviser, TAM shall pay the Subadviser out of the advisory fee it receives with respect to the Fund, and only to the extent thereof, as promptly as possible after the last day of each month, a fee, computed daily at an annual rate set forth opposite the Fund’s name on Schedule A annexed hereto. The first payment of the fee shall be made as promptly as possible at the end of the month succeeding the effective date of this Agreement, and shall constitute a full payment of the fee due the Subadviser for all services prior to that date. If this Agreement is terminated as of any date not the last day of a month, such fee shall be paid as promptly as possible after such date of termination, shall be based on the average daily net assets of the Fund or, if less, the portion thereof comprising the Allocated Assets, in that period from the beginning of such month to such date of termination, and shall be prorated according to the ratio that the number of business days in such period bears to the number of business days in such month. The average daily net assets of the Fund, or portion thereof comprising the Allocated Assets, shall in all cases be based only on business days and be computed as of the time of the regular close of business of the New York Stock Exchange, or such other time as stated in the Fund’s then-current Prospectus or as may be determined by the Board.
7. Compensation of Trustees, Officers and Employees.No Trustee, officer or employee of the Trust or the Fund shall receive from the Trust or the Fund any salary or other compensation as such Trustee, officer or employee while he is at the same time a director, officer, or employee of the Subadviser or any affiliated company of the Subadviser, except as the Board may decide. This paragraph shall not apply to Trustees, executive committee members, consultants and other persons who are not regular members of the Subadviser’s or any affiliated company’s staff.
8. Term. This Agreement shall continue in effect with respect to the Fund, unless sooner terminated in accordance with its terms, for two years from its effective date, and shall continue in effect from year to year thereafter, provided such continuance is specifically approved at least annually by the vote of a majority of the Trustees who are not parties hereto or interested persons of any such party, cast in person at a meeting called for the purpose of voting on the approval of the terms of such renewal, and by either the Board or the affirmative vote of a majority of outstanding voting securities of that Fund.
9. Termination. This Agreement may be terminated with respect to the Fund at any time, without penalty, by the Board or by the shareholders of the Fund acting by vote of at least a majority of its outstanding voting securities. This Agreement may also be terminated by TAM upon written notice to the Subadviser, without the payment of any penalty. The Subadviser may terminate the Agreement only upon giving 90 days’ advance written notice to TAM. This Agreement shall terminate automatically in the event of its assignment by the Subadviser and shall not be assignable by TAM without the consent of the Subadviser. For the avoidance of doubt, it is understood that this Agreement may be amended, terminated or not renewed as to one or more Funds without affecting the other Funds hereunder.
10. Use of Name. TAM and the Trust are authorized to use the name of the Subadviser and any marks, symbols or logos of the Subadviser in registration statements, advertising or otherwise. If this Agreement is terminated with respect to the Fund and the Subadviser no longer serves as subadviser to the Fund, the Subadviser reserves the right to withdraw from the Trust the right to the use of its name and its marks, symbols or logos that misleadingly imply a continuing relationship between the Fund and the Subadviser or any of its affiliates, except to the extent that continued use is required by applicable laws, rules, and regulations.
11. Liability of the Subadviser.The Subadviser may rely on information reasonably believed by it to be accurate and reliable. The Subadviser assumes no responsibility under this Agreement other than to render the services called for hereunder, in good faith, and shall not be liable for any error of judgment or mistake of law, or for any loss arising out of any investment or for any act or omission in the execution of securities transactions for the Fund, provided that nothing in this Agreement shall protect the Subadviser against any liability to TAM or the Fund to which the Subadviser would otherwise be subject by reason of willful misfeasance, bad faith, or gross negligence in the performance of its duties or by reason of its reckless disregard of its obligations and duties hereunder. As used in this Section 11, the term the “Subadviser” shall include any affiliates of the Subadviser performing services for the Trust or the Fund contemplated hereby and the partners, shareholders, directors, officers and employees of the Subadviser and such affiliates.
A-4
12. Registration Statement Disclosures. The Subadviser represents, warrants and agrees that it has reviewed the Trust’s current registration statement on FormN-1A with respect to the Fund as filed with the SEC and any amendments or supplements thereto, including without limitation any supplements filed pursuant to Rule 497 under the Securities Act of 1933 (as so amended and supplemented from time to time, the “Registration Statement”) and agrees to promptly review future amendments or supplements to the Registration Statement that relate to the Subadviser or the Fund, filed with the SEC (or which will be filed with the SEC in the future) and represents and warrants that, solely with respect to the disclosure respecting or relating to the Subadviser, including any performance information the Subadviser provides that is included in or serves as the basis for information included in the Registration Statement, as of the date of this Agreement, and as of the date of any future amendments or supplements to the Registration Statement, the Registration Statement does not contain any untrue statement of any material fact or omit any statement of material fact which was required to be stated therein or necessary to make the statements contained therein not misleading.
The Subadviser further agrees to notify TAM and the Trust promptly of any statement respecting or relating to the Subadviser contained in the Registration Statement that becomes untrue in any material respect or if the Registration Statement omits any statement of material fact respecting or relating to the Subadviser that is required to be stated therein or necessary to make the statements contained therein not misleading.
With respect to the disclosure respecting the Fund, the Subadviser represents, warrants and agrees that the description in the Registration Statement, including the Fund’s investment objective, investment strategies and risks (the “Description”), as of the date of this Agreement and as of the date of any future amendments or supplements to the Registration Statement, is consistent with the manner in which the Subadviser is managing the Fund, and the identification and description of risks in the Registration Statement is inclusive of, and accurately describes in all material respects, all material risks known to the Subadviser that may arise in connection with the management of the Fund by the Subadviser.
The Subadviser further agrees to notify TAM and the Trust promptly in the event that the Subadviser becomes aware that the Description for a Fund is inconsistent with the manner in which the Subadviser is managing the Fund, or in the event that the identification and description of risks in the Registration Statement fails to include, or accurately describe in all material respects, all material risks known to the Subadviser that may arise in connection with the management of the Fund by the Subadviser.
13. Use of Name. TAM and the Trust are authorized to use the name of the Subadviser and any marks, symbols or logos of the Subadviser in registration statements, advertising or otherwise. If this Agreement is terminated with respect to the Fund and the Subadviser no longer serves as subadviser to the Fund, the Fund and the Adviser shall cease using its name and its marks, symbols or logos as soon as reasonably practicable, except to the extent that continued use is required by applicable laws, rules, and regulations.
14. Meanings of Certain Terms. For the purposes of this Agreement, the Fund’s “net assets” shall be determined as provided in the Fund’s then-current Prospectus and Statement of Additional Information and the terms “assignment,” “interested person,” and “majority of the outstanding voting securities” shall have the meanings given to them by Section 2(a) of the 1940 Act, subject to such exemptions as may be granted by the SEC by any rule, regulation or order.
15. Amendments. No provision of this Agreement may be changed, waived, discharged or terminated orally with respect to the Fund, but only by an instrument in writing signed by the party against which enforcement of the change, waiver, discharge or termination is sought. No material amendment of the Agreement shall be effective with respect to the Fund until approved, if so required by the 1940 Act, by vote of the holders of a majority outstanding voting securities of that Fund. Schedule A hereto may be amended at any time to add additional series of the Trust as agreed by the Trust, TAM and the Subadviser.
16. Books and Records. The Subadviser agrees that it will keep records relating to its services hereunder in accordance with all applicable laws, and in compliance with the requirements of Rule31a-3 under the 1940 Act, the Subadviser hereby agrees that any records that it maintains for the Fund are the property of the Fund, and further agrees to surrender promptly to the Fund any of such records upon the Fund’s request. The Subadviser further agrees to arrange for the preservation of the records required to be maintained by Rule31a-1 under the 1940 Act for the periods prescribed by Rule31a-2 under the 1940 Act.
A-5
17. Independent Contractor. In the performance of its duties hereunder, the Subadviser is and shall be an independent contractor and, unless otherwise expressly provided herein or otherwise authorized in writing, shall have no authority to act for or represent the Fund or TAM in any way or otherwise be deemed to be an agent of the Fund or TAM.
18. Miscellaneous. This Agreement embodies the entire agreement and understanding between the parties hereto, and supersedes all prior agreements and understandings relating to the subject matter hereof. Should any part of this Agreement be held or made invalid by a court decision, statute, rule or otherwise, the remainder of this Agreement shall not be affected thereby. This Agreement shall be binding on and shall inure to the benefit of the parties hereto and their respective successors.
19. Third Party Beneficiaries. The parties hereto acknowledge and agree that the Trust and the Fund are third-party beneficiaries as to the covenants, obligations, representations and warranties undertaken by the Subadviser under this Agreement and as to the rights and privileges to which TAM is entitled pursuant to this Agreement, and that the Trust and the Fund are entitled to all of the rights and privileges associated with such third-party-beneficiary status. This Agreement does not, and is not intended to, create any other third-party beneficiary or otherwise confer any rights, privileges, claims or remedies upon any shareholder or other person other than the Trust, the Fund, and the parties and their respective successors and permitted assigns.
20. Governing Law and Forum Selection. This Agreement shall be construed and the provisions thereof interpreted under and in accordance with the laws of the State of New York without regard to conflicts of laws principles. Any legal suit, action or proceeding related to, arising out of or concerning this Agreement shall be brought only in the U.S. District Court for the Southern District of New York, or if such action may not be brought in that court, then such action shall be brought in the New York Supreme Court (the “Designated Courts”). Each party (a) consents to jurisdiction in the Designated Courts; (b) waives any objection to venue in either Designated Court and (c) waives any objection that either Designated Court is an inconvenient forum. For any action commenced in the New York Supreme Court, application shall be submitted to the Commercial Division.
21. Interpretation.Nothing contained herein shall be deemed to require the Trust to take any action contrary to its Governing Documents, or any applicable statutory or regulatory requirement to which it is subject or by which it is bound, or to relieve or deprive the Board of its responsibility for and control of the conduct of the affairs of the Trust.
22. Further Assurances. Each party agrees to perform such further acts and execute such further documents as are reasonably necessary to effectuate the purposes of this Agreement and the arrangements contemplated thereby, including without limitation concerning the winding down or liquidation of any Fund investments.
[signature page to follow]
A-6
The parties hereto have caused this Agreement to be executed by their duly authorized signatories as of the date and year first above written.
TRANSAMERICA ASSET MANAGEMENT, INC. | ||
By: | /s/ Christopher A. Staples | |
Name: | Christopher A. Staples | |
Title: | Senior Director, Investments | |
CLARIVEST ASSET MANAGEMENT LLC | ||
By: | /s/ Tiffany A. Ayres | |
Name: | Tiffany A. Ayres | |
Title: | Executive Vice President, General Counsel and Chief Compliance Officer |
A-7
Schedule A
FUNDS | INVESTMENT SUB-ADVISORY FEE* | |
Transamerica Emerging Markets Equity | 0.49% of assets up to $250 million; 0.45% over $250 million up to $500 million; 0.43% over $500 up to $1 billion; and 0.41% of net assets in excess of $1 billion | |
Transamerica International Stock | 0.25% of assets up to $500 million; 0.23% of assets over $500 million up to $1 billion; 0.22% of assets over $1 billion up to $2 billion; 0.21% of assets over $2 billion up to $3 billion; 0.20% of net assets in excess of $3 billion |
* | As a percentage of average daily net assets on an annual basis. |
Relationship Pricing: ClariVest Asset Management LLC | ||||||||||||||||
Projected Assets: $1.3B |
| |||||||||||||||
Fee Type | Breakpoints | |||||||||||||||
$0 - $500M | $500M - $1.5B | $1.5B - $3B | Over $3B | |||||||||||||
Sub-Advisory Discount1 | 0.0 | % | 5.0 | % | 7.5 | % | 10.0 | % |
1 | Sub-advisory discount will apply to all Funds and Portfoliossub-advised by ClariVest Asset Management LLC that do not benefit from aggregation across like strategies. Initially this will apply to Transamerica Emerging Markets Equity and Transamerica International Stock. |
TRANSAMERICA FUNDS
Transamerica Emerging Markets Equity
Transamerica International Stock
1801 California Street, Suite 5200
Denver, CO 80202
Telephone:
1-888-233-4339
NOTICE OF INTERNET AVAILABILITY OF INFORMATION STATEMENT
This communication presents only an overview of the more complete Information Statement that is available to you on the internet relating to Transamerica Emerging Markets Equity and Transamerica International Stock (each a “Fund” and collectively, the “Funds”). Transamerica Emerging Markets Equity and Transamerica International Stock are series of Transamerica Funds (the “Trust”). We encourage you to access and review all of the important information contained in the Information Statement.
The following material is available for view:Information Statement
The Information Statement is to inform shareholders that on March 31, 2019, Eagle Asset Management, Inc. (“Eagle”) increased its ownership interest in ClariVest Asset Management LLC (“ClariVest”). ClariVest is now a wholly-owned subsidiary of Eagle. This transaction constituted an “assignment,” as that term is defined in the Investment Company Act of 1940, as amended, of the priorsub-advisory agreement with ClariVest and resulted in the automatic termination of the agreement. In anticipation of the transaction, the Board approved the continued retention of ClariVest as the Funds’sub-adviser and approved a newsub-advisory agreement with ClariVest to take effect upon the closing of the transaction. ClariVest continues to act assub-adviser for each Fund under the newsub-advisory agreement. TAM continues to serve as each Fund’s investment manager. In approving the newsub-advisory agreement, the Board considered, among other things, that the transaction is not expected to result in any diminution in the nature, extent and quality ofsub-advisory services provided by ClariVest to the Funds. The Information Statement provides information regarding the newsub-advisory agreement.
The Trust and TAM have received an exemptive order (the “Order”) from the U.S. Securities and Exchange Commission that permits TAM to enter into and materially amendsub-advisory agreements (withnon-affiliated entities) with the approval of the Board of Trustees, including a majority of Board Members who are not parties to the agreements and are not interested persons, as defined in the 1940 Act, of the parties to the agreement, without obtaining shareholder approval. The Order instead requires that an Information Statement be sent to you. In lieu of physical delivery of the Information Statement, the Trust will make the Information Statement available to you online.
The Information Statement will be available on the Transamerica website until at least December 31, 2019 athttps://www.transamerica.com/media/tf-clarivest-to-eagle-info-statement.pdf. A paper or email copy of the Information Statement may be obtained, without charge, by contacting the Funds at1-888-233-4339.
If you want to receive a paper ore-mail copy of the Information Statement, you must request one. There is no charge to you for requesting a copy.